(19)
(11) EP 3 107 932 A1

(12)

(43) Date of publication:
28.12.2016 Bulletin 2016/52

(21) Application number: 15705594.8

(22) Date of filing: 17.02.2015
(51) International Patent Classification (IPC): 
C07K 14/47(2006.01)
C12N 15/62(2006.01)
(86) International application number:
PCT/EP2015/053307
(87) International publication number:
WO 2015/121496 (20.08.2015 Gazette 2015/33)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 17.02.2014 EP 14305210

(71) Applicants:
  • INSERM (Institut National de la Santé et de la Recherche Médicale)
    75013 Paris (FR)
  • Université Paris Diderot - Paris 7
    75013 Paris (FR)
  • Assistance Publique-Hôpitaux de Paris (APHP)
    75004 Paris (FR)

(72) Inventors:
  • POYET, Jean-Luc
    F-75010 Paris (FR)
  • BRUZZONI-GIOVANELLI, Heriberto
    F-75010 Paris (FR)
  • JAGOT-LACOUSSIERE, Léonard
    F-75010 Paris (FR)

(74) Representative: Collin, Matthieu 
Inserm-Transfert Paris Biopark 7, rue Watt
75013 Paris
75013 Paris (FR)

   


(54) METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CANCER